Kaletra Information
What's inside Kaletra
Kaletra Active Ingredients: ritonavir, lopinavir, details.| Kaletra Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Kaletra 200 mg-50 mg | tablet | oral | 1.0 each | OTC |
| Kaletra 200 mg-50 mg | tablet | oral | 1.0 each | OTC |
| Kaletra 133.3 mg-33.3 mg | capsule | oral | 1.0 each | OTC |
| Kaletra 400 mg-100 mg/5 mL | liquid | oral | 5.0 milliliter(s) | OTC |
Recent Kaletra Side Effects
Posted by sthomasmama4 over 2 years ago
I SEEN MY DOCTOR TODAY AND I ASK HER WHY I AM HAVING TROUBLE LOSING MY LITTLE TIRE RING UNDER MY CHEST WHERE THE STOMACH IS A...
Kaletra in the News
Viracept Pulled From NIH Guidelines for Pediatric HIV Treatments - FDA news (subscription)
... Antiretroviral Agents in Pediatric HIV Infection advise physicians to prescribe Abbott Laboratories’ Kaletra (lopinavir) or Norvir (ritonavir) instead. ...
Mon Mar 10 17:40:53 -0400 2008
Minister underattack for plan to reverse CL - Bangkok Post
... government would revoke compulsory licences for three Aids and heart drugs _ Efavirenz, Kaletra, and Plavix _ issued in November 2006 and January 2007. ...
Mon Feb 18 20:34:02 -0500 2008
We’re Taking Your Medicine, Literally - River Cities Reader
The first, the HIV/AIDS drug Kaletra, is produced by the US-based Abbott Laboratories. The second, the heart-disease drug Plavix, is manufactured by Sanofi ...
Wed Mar 05 09:18:25 -0500 2008
Kaletra Chemical Information
ritonavir - A synthetic aromatic derivative with antiviral properties. Ritonavir is a peptidomimetic agent that inhibits both HIV-1 and HIV-2 proteases, thereby preventing the cleavage of Gag-Pol polyproteins and resulting in the production of noninfectious viral particles. This agent is more active against HIV-1. Because ritonavir targets the HIV replication cycle after translation and before assembly, it is active in chronically infected cells that generally are not affected by nucleoside reverse transcriptase inhibitors. (NCI04)
lopinavir - A protease inhibitor used against human immunodeficiency virus (HIV). Lopinavir competitively inhibits the HIV-1 protease, an enzyme that mediates the cleavage of Gag, Gag-Pol and Nef precursor polypeptides into their mature proteins, including protease, reverse transcriptase, and integrase. Inhibition of HIV-1 protease prevents cleavage of the viral polyprotein precursor and results in the release of immature, noninfectious virions.
Kaletra RSS Feed
